Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.95
Delayed Data
As of May 22
 -0.04 / -0.57%
Today’s Change
4.00
Today|||52-Week Range
11.72
-19.56%
Year-to-Date
PetMed (PETS) Beats Earnings, Revenue Estimates in Q4
May 09 / Zacks.com - Paid Partner Content
Haemonetics (HAE) Tops Q4 Earnings, Sales, Issues 2018 View
May 09 / Zacks.com - Paid Partner Content
Henry Schein (HSIC) Tops Q1 Earnings, Reaffirms '17 View
May 09 / Zacks.com - Paid Partner Content
Phibro (PAHC) Posts In Line Earnings in Q3, Revises View
May 09 / Zacks.com - Paid Partner Content